Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● From a short-term investment perspective, the company presents a deteriorated fundamental configuration.


Strengths

● Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 64% by 2025.

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Considering the small differences between the analysts' various estimates, the group's business visibility is good.


Weaknesses

● With an expected P/E ratio at 58.22 and 42.38 respectively for both the current and next fiscal years, the company operates with high earnings multiples.

● The company's "enterprise value to sales" ratio is among the highest in the world.

● The company appears highly valued given the size of its balance sheet.

● The valuation of the company is particularly high given the cash flows generated by its activity.

● The company is not the most generous with respect to shareholders' compensation.

● The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.

● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.

● Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.

● Over the past four months, analysts' average price target has been revised downwards significantly.

● The average consensus view of analysts covering the stock has deteriorated over the past four months.

● Over the past twelve months, analysts' opinions have been revised negatively.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.